Katsuhiko Yanaga
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 11, 2022
Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.Tadashi Uwagawa, Taro Sakamoto, Takeshi Gocho
|Dec 02, 2021
Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy.Hironari Kawai, Yosuke Osawa, Michitaka Matsuda
|Sep 02, 2021
Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.Naoki Takada, Hiroshi Sugano, Yoshihiro Shirai
|Aug 02, 2021
Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.Michinori Matsumoto, Katsuhiko Yanaga, Hiroaki Shiba
|Mar 13, 2019
Correction: Hiroshi Sugano et al. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10, 386.Hiroshi Sugano, Yoshihiro Shirai, Takashi Horiuchi
|Oct 14, 2018
Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity.Yuki Fujiwara, Yi Sun, Robert J Torphy
Pageof 1
Frequent Collaborators
1 joint publications
Yuki Fujiwara
1 joint publications
Hiroshi Sugano
1 joint publications
Michinori Matsumoto
1 joint publications
Hiroaki Shiba
1 joint publications
Shigeki Wakiyama
1 joint publications
Taro Sakamoto
1 joint publications
Yasuro Futagawa
1 joint publications
Takeshi Gocho
1 joint publications
Yuichi Ishida
1 joint publications
Toru Ikegami
